Improvement of breast cancer prognostication using cell kinetic-based silver-stainable nucleolar organizer region quantification of the MIB-1 positive tumor cell compartment

Virchows Archiv

Volumn 438, Issue 5, 2001, Pages 478-484

  Biesterfeld, Stefan ^a   Farokhzad, Faraneh ^a,b   Klüppel, Dominik ^a   Schneider, Susanne ^a   Hufnagl, Peter ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

AgNOR; Breast cancer; Image cytometry; MIB 1; Survival analysis

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CELL KINETICS; CHROMOSOME NOR; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANTIGENS, NUCLEAR; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE CYTOMETRY; IMAGE PROCESSING, COMPUTER-ASSISTED; KI-67 ANTIGEN; MIDDLE AGED; NUCLEAR PROTEINS; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; SILVER STAINING; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035041358     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000351     Document Type: Article

References (50)

1. 1. Aaltomaa S, Lipponen P, Syrjänen K (1993) Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer. Anticancer Res 13:533-538
2. 2. Bànkfalvi A, Schmitz K, Mock T, Kemper M, Cubick C, Böcker W (1998) Relationship between AgNOR proteins, Ki-67 antigen, p53 immunophenotype and differentiation markers in archival breast carcinomas. Anal Cell Pathol 17:231-242
3. 3. Bellotti M, Elsner B, Kahn A, Bezodnick L, Pisilli L, Greco P (1997) Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen. Anal Quant Cytol Histol 19:139-144
4. 4. Biesterfeld S, Klüppel D, Koch R, Schneider S, Steinhagen G, Mihalcea AM, Schröder W (1998) Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR. J Pathol 185:25-31
5. 5. Biesterfeld S, Ruoß E, Hufnagl P, Martin H (1994) Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens. Zentralbl Pathol 140:41-48
6. 6. Bigras G, Marcelpoil R, Brambilla E, Brugal G (1996) Interest of targeting AgNORs measurement in cycling cells: in vivo cell kinetic evaluation of non-small cell lung cancer. Anal Cell Pathol 11:183-198
7. 7. Brugal G (1994) Interpretation of proliferation markers. In: Wied GL, Bartels PH, Rosenthal DL, Schenk U (eds) Compendium of the computerized cytology and histology laboratory. Tutorials of Cytology, Chicago, pp 234-240
8. 8. Costa ALL, Araújo NS, Pinto DS, Araújo VC (1999) PCNA/AgNOR and Ki-67/AgNOR double staining in oral squamous cell carcinoma. J Oral Pathol Med 28:438-441
9. 9. Cubick G, Seminow G, Hertle U, Schmid KW, Öfner D (1998) Standardized AgNOR analysis in radically resected prostate cancer - correlation with PSA values and survival. Cell Anal Pathol 16:113-114
10. 10. Delahunt B, Bethwaite PB, Nacey JN, Ribas JL (1993) Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver staining nucleolar organizer region numbers. J Pathol 170:471-477
11. 11. Delahunt B, Bethwaite PB, Thornton A, Ribas JL (1995) Proliferation of renal cell carcinoma assessed by fixation resistant polyclonal Ki 67 antibody labeling. Correlation with clinical outcome. Cancer 75:2714-2719
12. 12. de Melo N, Matutes E, Cordone I, Morilla R, Catovksy D (1992) Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders. J Clin Pathol 45:660-663
13. 13. Derenzini M, Pession A, Trerè D (1990) The quantity of nucleolar silver stained proteins is related to proliferating activity in cancer cells. Lab Invest 63:137-140
14. 14. Derenzini M, Pession A, Farabegoli F, Trerè D, Badiali M, Dehan P (1991) Relationship between interphase nucleolar organizer regions and growth rate in two neuroblastoma cell lines. Am J Pathol 134:925-932
15. 15. di Stefano D, Mingazzini L, Scucchi L, Doetti M, Marinozzi V (1991) A comparative study on histopathology, hormone receptors, peanut lectin binding, Ki67 immunostaining and nucleolar organizer region-associated proteins in human breast cancer. Cancer 67:463-471
16. 16. Giuffrè G, Barresi G, Speciale G, Gioffre Sarnelli R, Florio MA, Tuccari G (1997) Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes? Eur J Histochem 41:111-118
17. 17. Giuffrè G, Caruso RA, Barresi G, Tuccari G (1998) Prognostic significance of standardized AgNOR analysis in early and advanced gastric carcinomas. Virchows Arch 433:261-266
18. 18. Hendricks JB, Rainer R, Munakata S (1995) Computer assisted and visual methods of assessing cellular proliferation in tissue sections from non-Hodgkin's lymphoma a comparison. Anal Quant Cytol Histol 17:383-388
19. 19. Hittmair A, Öfner D, Offner F, Feichtinger H, Ensinger C, Rogatsch H, Mikuz G (1994) In vitro investigations of interphase and metaphase argyrophilic nucleolar organizer regions and cellular proliferation in the human urothelial cancer cell line HOK-1. Virchows Arch 424:149-154
20. 20. Jain S, Filipe MI, Hall PA, Waseem N, Lane DP, Levison DA (1991) Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 44:655-659
21. 21. Janmohamed RM, Murray PG, Crocker J, Leyland MJ (1990) Sequential demonstration of nucleolar organizer regions and Ki-67 immunolabeling in non-Hodgkin's lymphoma. Clin Lab Haematol 12:395-399
22. 22. Kesari AL, Chellam VG, Nair PP, Madhavan J, Nair P, Nair MK, Pillai MR (1997) Tumor proliferative fraction in infiltrating duct carcinoma. Gen Diagn Pathol 143:219-224
23. 23. Korek G, Martin H, Wenzelides K (1991) A modified method for the detection of nuleolar organizer regions (AgNORs). Acta Histochem 90:155-157
24. 24. Korkolopoulou P, Angelopoulou MK, Kontopidou F, Tsengas A, Patsouris E, Kittas C, Pangalis GA (1998) Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and p53 in non-Hodgkin's lymphomas. Leuk Lymphoma 30:625-636
25. 25. Lorenzato M, Abboud P, Lechki C, Browarnyi F, O'Donohue MF, Ploton D, Adnet JJ (2000) Proliferation assessment in breast cancer: a double-staining technique for AgNOR quantification in MIB-1 positive cells especially adapted for image cytometry. Micron 31:151-159
26. 26. Maeda K, Chung YS, Onoda N, Kato Y, Nitta A, Arimoto Y, Yamada N, Kondo Y, Sowa M (1994) Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis. Cancer 73:528-533
27. 27. Mourad WA, Sneige N, Katz RL, Ordonez NG (1994) Correlations of two AgNOR counts with Ki-67 labelling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma. Diagn Cytopathol 10:113-119
28. 28. Munakata S, Hendricks JB (1994) A multilabeling technique for simultaneous demonstration and quantitation of Ki 67 and nucleolar organizer regions (AgNORs) in paraffin embedded tissue. J Histochem Cytochem 42:789-793
29. 29. Nakae S, Nakamura T, Ikegawa R, Yoshioka H, Shirono J, Tabuchi Y (1998) Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer. J Surg Oncol 69:28-35
30. 30. Öfner D, Hittmair A, Marth C, Öfner C, Tötsch M, Daxenbichler G, Mikuz G, Margreiter R, Schmid KW (1992) Relationship between quantity of silver-stained nucleolar organizer regions associated proteins (AgNORs) and population doubling time in ten breast cancer cell lines. Pathol Res Pract 188:742-746
31. 31. Öfner D, Bànkfalvi A, Riehemann K, Böcker W, Schmid KW (1994) Wet autoclave pretreatment improves the visualisation of silver stained nucleolar organizer regions associated proteins (AgNORs) in routinely formalin-fixed and paraffin-embedded tissues. Mod Pathol 7:946-950
32. 32. Öfner D, Aubele M, Biesterfeld S, Derenzini M, Giminez-Mas JA, Hufnagl P, Ploton D, Trerè D, Rüschoff J (1995) Guidelines of AgNOR quantification - first update. Virchows Arch 427:341-342
33. 33. Öfner D, Riedmann B, Maier H, Hittmair A, Rumer A, Totsch M, Spechtenhauser B, Böcker W, Schmid KW (1995) Standardized staining and analysis of argyrophilic nucleolar organizer region associated proteins (AgNORs) in radically resected colorectal adenocarcinoma. Correlation with tumour stage and long term survival. J Pathol 175:441-448
34. 34. Öfner D, Bier B, Heinrichs S, Berghorn M, Dünser M, Hagemann HA, Langer D, Böcker W, Schmid KW (1996) Demonstration of silver stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long term survival. Breast Cancer Res Treat 39:165-176
35. 35. Pich A, Chiusa L, Margaria E (2000) Prognostic relevance of AgNORs in tumor pathology. Micron 31:133-141
36. 36. Piffkò J, Bànkfalvi À, Öfner D, Rasch D, Joos U, Schmid KW (1997) Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas. J Pathol 182:450-456
37. 37. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ (1986) Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 18:5-14
38. 38. Railo M, Nordling S, von Boguslawsky K, Leivonen M, Kyllonen L, von Smitten K (1993) Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 68:579-583
39. 39. Riedmann B, Maier H, Weiss H, Schwab G, Labeck B, Tötsch M, Schmid K, Öfner D (1998) Silver stained nucleolar organizer regions associated protein (AgNOR) analysis: a major prognostic factor in gastric carcinoma. Tumordiagn Ther 19:35-41
40. 40. Rüschoff J, Fauser G, Knüchel R, Hofstädter F (1994) AgNOR quantification with special reference to staining patterns. Zentralbl Pathol 140:23-30
41. 41. Sahin AA, Ro J, Ro JY, Blick MB, el Naggar AK, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AG (1991) Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer 68:549-557
42. 42. Sallinen PK, Haapasalo HK, Visakorpi T, Helen PT, Rantala IS, Isola JJ, Helin HJ (1994) Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 174 275-282
43. 43. Shome DK, Khurana N (1999) Distinctive AgNOR patterns of myeloid and lymphoid blasts in acute leukemia. Am J Hematol 61:149-152
44. 44. Sirri V, Perssion A, Trerè D, Montanaro L, Derenzini M (1995) Proportionally constant quantitative transmission of nucleolin and protein B23 in cycling cancer cells. J Clin Pathol 48:M264-M268
45. 45. Smith FG, Murray PG, Crocker J (1993) Correlation between PCNA and AgNOR scores in non Hodgkin's lymphomas using sequential staining technique. J Clin Pathol 46:28-31
46. 46. Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kuhn R, Wittekind CW (1996) Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer 77:164-171
47. 47. Tomobe M, Shimazui T, Uchida K, Hinotsu S, Akaza H (1999) Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor. J Urol 162:63-68
48. 48. Tötsch M, Öfner D, Maier H, Watzka SBC, Salzer M, Schmid KW (1995) Argyrophilic nucleolar organizer region associated proteins (AgNORs) in adenocarcinoma and squamous cell carcinoma of the lung - correlation with tumour stage and long-term survival. Pathol Res Pract 191:800
49. 49. Trerè D, Pession A, Derenzini M (1989) The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp Cell Res 184:131-137
50. 50. Yue L, Iwai M, Furuta I (1999) Evaluation of argyrophilic nucleolar organizer regions in tongue squamous cell carcinomas. Oral Oncol 35:70-76